vt3989
vivace therapeutics,vivace therapeutics
['vt3989 i', 'mesothelioma', 'vt3989']
the #oncoalerttoptweet day 3 #aacr23 tweet by the hippo-yap-tead pathway is druggable! impressive activity from first in class first in human phase 1 trial of yap inhibitor vt3989 in mesothelioma and nf2 alterations! case a young patient with 
🌐 Worldwide Network of Oncology Professionals & Patient Advocates with the common goal of ending cancer, we are Oncology360 degrees 🌎 We are #OncoAlert 🚨